Meclophenamic acid
Brand names,
Meclophenamic acid
Analogs
Meclophenamic acid
Brand Names Mixture
Meclophenamic acid
Chemical_Formula
C5H4N4S
Meclophenamic acid
RX_link
http://www.rxlist.com/cgi/generic2/mercaptopurine.htm
Meclophenamic acid
fda sheet
Meclophenamic acid
msds (material safety sheet)
Meclophenamic acid
Synthesis Reference
No information avaliable
Meclophenamic acid
Molecular Weight
152.178 g/mol
Meclophenamic acid
Melting Point
313 oC
Meclophenamic acid
H2O Solubility
6.85 mg/mL
Meclophenamic acid
State
Solid
Meclophenamic acid
LogP
0.335
Meclophenamic acid
Dosage Forms
Tablet (50-mg, scored) for oral administration
Meclophenamic acid
Indication
For remission induction and maintenance therapy of acute lymphatic leukemia.
Meclophenamic acid
Pharmacology
Mercaptopurine is one of a large series of purine analogues which interfere with nucleic acid biosynthesis and has been found active against human leukemias. It is an analogue of the purine bases adenine and hypoxanthine. It is not known exactly which of any one or more of the biochemical effects of mercaptopurine and its metabolites are directly or predominantly responsible for cell death.
Meclophenamic acid
Absorption
Clinical studies have shown that the absorption of an oral dose of mercaptopurine in humans is incomplete and variable, averaging approximately 50% of the administered dose. The factors influencing absorption are unknown.
Meclophenamic acid
side effects and Toxicity
Signs and symptoms of overdosage may be immediate such as anorexia, nausea, vomiting, and diarrhea; or delayed such as myelosuppression, liver dysfunction, and gastroenteritis. The oral LD50 of mercaptopurine was determined to be 480 mg/kg in the mouse and 425 mg/kg in the rat.
Meclophenamic acid
Patient Information
No information avaliable
Meclophenamic acid
Organisms Affected
Humans and other mammals